HSPA12B attenuates acute lung injury during endotoxemia in mice

HSPA12B attenuates acute lung injury during endotoxemia in mice
复制标题

HSPA12B 可减轻小鼠内毒素血症期间的急性肺损伤。

DOI:
10.1016/j.intimp.2015.09.022
复制
发表时间:
2015-12-01
影响因子:
5.6
通讯作者:
Liu,Li
Liu,Li
中科院分区:
医学2区
文献类型:
--
作者:
Zhang,Xiaojin;Li,Jingjin;Liu,Li

文献摘要

相似文献

急性肺损伤(ALI)是脓毒症/脓毒性休克的重要表现。热休克蛋白A12 B(HSPA 12 B)是一种内皮细胞表达的热休克蛋白,对脂多糖(LPS)诱导的心肌和内皮细胞炎症反应具有负性调节作用。然而,目前尚不清楚HSPA 12 B是否对脓毒症/脓毒性休克期间的ALI发挥保护作用。在这项研究中,我们用LPS处理HSPA 12 B转基因小鼠(Tg)和野生型同窝小鼠(WT)6 h,以诱导内毒素血症。LPS处理显著引起肺损伤,如WT小鼠肺中的微结构破坏、血管渗漏和中性粒细胞募集所证明的。然而,LPS诱导的肺损伤在Tg小鼠中显著减弱。此外,与WT小鼠相比,Tg小鼠肺中LPS诱导的细胞外信号调节激酶(ERK)活化以及细胞间粘附分子-1(ICAM-1)和环氧合酶-2(考克斯-2)的上调受到抑制。此外,与WT小鼠相比,Tg肺显示出显著较低水平的血管内皮生长因子(VEGF)。我们的研究结果表明,肺保护作用的HSPA 12 B对内毒素的挑战,这表明管理HSPA 12 B的表达可以作为一个潜在的治疗目标,在脓毒症/脓毒性休克的ALI。
Acute lung injury (ALI) is a critical manifestation of sepsis/septic shock. Heat shock protein A12B (HSPA12B), an endothelial cell–expressed heat shock protein, shows a negative regulation of lipopolysaccharide (LPS)-induced inflammation in myocardium and endothelial cells. However, it is unclear whether HSPA12B exerts protective effects against ALI during sepsis/septic shock. In this study, we treated HSPA12B transgenic mice (Tg) and wild type littermates (WT) with LPS for 6 h to induce endotoxemia. LPS treatment significantly caused pulmonary injuries as evidenced by microarchitecture destruction, vascular leakage and neutrophil recruitment in lungs of WT mice. However, the LPS-induced pulmonary injuries were significantly attenuated in Tg mice. Moreover, the LPS-induced activation of extracellular signal-regulated kinases (ERKs) and upregulation of intercellular adhesion molecule-1 (ICAM-1) and Cyclooxygenase-2 (Cox-2) were inhibited in Tg lungs compared with that in WT mice. Additionally, Tg lungs showed a significant lower level of vascular endothelial growth factor (VEGF) compared with WT mice. Our results demonstrate a pulmonary protective effect of HSPA12B against endotoxin challenge, which indicates management of HSPA12B expression could serve as a potential therapeutic target for ALI during sepsis/septic shock.